With its major international divestments successfully completed, Fortis Healthcare has now firmly strengthened its strategic focus on India. Mr Aditya Vij, the CEO with the company, since mid-2011, will be transitioning from Fortis by the end of the year, to pursue his family business and investments, as he sets a future professional agenda for himself, aspects he has been desirous of concentrating on for some time now.
Executive Vice Chairman, Mr Shivinder M. Singh, will assume additional responsibility for the Company’s operations in the interim while the search for a new CEO is on.
Aditya Vij said, “The Company is on a strong footing. With Fortis’ eminent doctors and key executives in focal positions of responsibility I feel confident that the Company’s future is in good hands. My personal commitments at this juncture require me to concentrate on my family business and investments, as I set a future professional agenda. I will be relinquishing my role with a sense of accomplishment and wish the entire Fortis Team, all success.”
Acknowledging and taking on record Aditya Vij's contribution to the Company, Malvinder M. Singh, Executive Chairman and Shivinder Singh, Executive Vice Chairman, said, "In his tenure during the last over three years, Aditya has led the team with maturity whilst driving the Company's performance agenda, putting it into its next phase of growth. He facilitated the smooth integration of the acquired Wockhardt hospitals and heightened the sensitivity of the operations team towards patient centric care and medical excellence. We wish Aditya the very best for the future.”
Post the international divestments Fortis is also realigning its talent to further consolidate and grow its business. In recent months it has structured the company to meet the country’s emergent challenges whilst improving organizational efficiency and effectiveness. The company has used a judicious mix of in house succession and the selective external infusion of experienced professionals to add to its delivery capability.
With the business now on a stable footing, Mr. Balinder Dhillon, President, Corporate Governance, is being elevated to the promoter Group office of - RHC Holdings Pvt. Ltd. (RHC) where his vast skill set and experience will be available to the entire group. RHC is the holding, investment and financial advisory company of the promoter group, with a portfolio of 5 listed businesses that include Fortis. Mr. Dhillon will assume his new role as Group President – Corporate Governance – RHC Holdings Pvt. Ltd. from April 1, 2015.
Congratulating Mr. Dhillon, on his elevation, Malvinder and Shivinder Singh said, “We value Dhillon’s numerous contributions, strategic counsel and insightful advice to the company. He has been a longstanding and invaluable member of our Apex leadership team that has successfully spearheaded the international acquisitions and divestments for the Company. Dhillon has set up and institutionalised the professional governance framework within Fortis, leading the Audit, Risk, Legal and Secretarial functions. He has raised the bar to an entirely new level putting in place robust risk assessment and audit mechanisms. We look forward to working with him as he takes on his additional responsibilities in creating a strong governance edifice for the group.”
Fortis in recent months has also structured the company for greater success, creating and assigning roles and responsibilities to augment and drive patient centric measures for improved clinical outcomes as well as for greater efficiency and organizational excellence.
The company has positioned many of its experienced executives in strategic roles and infused fresh talent in medical operations, Training and Development, Sales and Marketing, to bring about greater alignment and traction in its ability to serve its customers better.
Significant changes that have been made include Mr Gagandeep Singh Bedi’s recent appointment as CFO. Mr. Bedi is a qualified chartered accountant with a long international track record at Philips and the past over 3 years with Fortis, as Head of Global Supply Chain and Shared Services.
Ms Sandra Subner has joined the company as Head of Medical Programme Management. Ms Subner brings to Fortis over 26 years of experience in the healthcare industry, across the world, in venerable institutions such as the Islington Health Authority, The Camden London, The Singapore General Hospital, Singapore, among others.
Air Marshal Dr. B.Keshav Rao (Retd) has joined Fortis as Regional Medical Director for Delhi/NCR. Dr Rao is a seasoned medical professional with over three decades of experience in the Armed Forces. Prior to Joining Fortis, he was the Director and Commandant of the prestigious AFMC, Pune.
Commander (Retd) Dr Kamal Cheema, with over three decades of experience, most of which has been with the Armed Forces in positions of great responsibility, joined Fortis recently, as Regional Medical Director, West and East Regions.
Major General (Retd) Dr Yash Pandey, has joined the prestigious Fortis Escorts Heart Institute, New Delhi, as its Medical Director. Dr Pandey was formerly the Additional Director General of the Armed Forces Medical Services and was responsible for the recruitment of top flight medical doctors into the three services.
Mr. Raj Gore, who has handled varied assignments within Fortis, including international operations in Mauritius and in Vietnam, has returned to India and has been inducted as Vice President – Operations, to lead the Company’s performance enhancement initiatives.
With these augmenting steps and its vast talent pool of existing medical and management professionals, Fortis is well positioned to leverage its expertise to address and capitalise on its current and emergent priorities in the fast evolving healthcare landscape.
About Fortis Healthcare Limited
Fortis Healthcare Limited is a leading integrated healthcare delivery service provider in India. The healthcare verticals of the company primarily comprise hospitals, diagnostics and day care specialty facilities. Currently, the company operates its healthcare delivery services in India, Singapore, Dubai, Mauritius and Sri Lanka with 55 healthcare facilities (including projects under development), approximately 10,000 potential beds and 270 diagnostic centres. In a global study of the 30 most technologically advanced hospitals in the world, its flagship, the Fortis Memorial Research Institute’ (FMRI), was ranked No.2, by ‘topmastersinhealthcare.com, and placed ahead of many other outstanding medical institutions in the world.
DISCLAIMER
This press release may contain forward-looking statements based on the currently held beliefs and assumptions of the management of the Company, which are expressed in good faith and, in their opinion, reasonable. Forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, financial condition, performance, or achievements of the Company results, to differ materially from the results, financial condition, performance or achievements expressed or implied by such forward-looking statements. Given these risks, uncertainties and other factors, recipients of this press release are cautioned not to place undue reliance on these forward-looking statements. The Company assumes no responsibility to publicly amend, modify or revise any forward looking statements, on the basis of any subsequent development, information or events, or otherwise. The information contained herein is subject to change without notice and past performance is not indicative of future results. The Company may alter, modify or otherwise change in any manner the content of this press release, without obligation to notify any person of such revision or changes.
No comments:
Post a Comment